{"podcast":{"title":"Neuro-Oncology: The Podcast","slug":"neuro-oncology-the-podcast-1565653","podcast_index_feed_id":1565653,"rss_url":"https://soc-neuro-onc.libsyn.com/rss","website_url":"https://soc-neuro-onc.libsyn.com","image_url":"https://static.libsyn.com/p/assets/e/f/5/2/ef52e509e1640133/Neuro-oncology_Podcast_G2b.jpg","author":"Neuro-Oncology","episode_count":146,"summary":"Neuro-Oncology: The Podcast will keep you up to date about the latest advances in the field as we present conversations with the authors of selected papers from Neuro-Oncology and its sister journals, Neuro-Oncology Practice and Neuro-Oncology Advances.","last_synced_at":"2026-07-24T20:19:44.205313+00:00","page_url":"https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653"},"episode":{"title":"Ivosidenib in predominantly recurrent IDH1-mutant glioma: A single-institution experience","slug":"ivosidenib-in-predominantly-recurrent-idh1-mutant-glioma-a-single-institution-experience","published_at":"2026-06-15T09:00:00+00:00","page_url":"https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/ivosidenib-in-predominantly-recurrent-idh1-mutant-glioma-a-single-institution-experience","show_page_url":"https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653","url":"https://soc-neuro-onc.libsyn.com/ivosidenib-in-predominantly-recurrent-idh1-mutant-glioma-a-single-institution-experience","audio_url":"https://traffic.libsyn.com/secure/soc-neuro-onc/nop-141.mp3?dest-id=2339594","summary":"Podcast Host and Interviewee: Host: John Fortunato Interviewee: Sofia Rael, Ugur Sener Podcast Description: Dr. John Fortunato interviews Dr. Sofia Rael and Dr. Ugur Sener on their recent manuscript, titled \" Ivosidenib in predominantly recurrent IDH1-mutant glioma: A single institution experience.\"","meta_description":"Podcast Host and Interviewee: Host: John Fortunato Interviewee: Sofia Rael, Ugur Sener Podcast Description: Dr. John Fortunato interviews Dr. Sofia Rael a…","key_points":[],"chapters":[],"topics":[],"duration_seconds":972,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/neuro-oncology-the-podcast-1565653/episodes/ivosidenib-in-predominantly-recurrent-idh1-mutant-glioma-a-single-institution-experience/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/ivosidenib-in-predominantly-recurrent-idh1-mutant-glioma-a-single-institution-experience.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}